An Experience-First Approach to Autistic Pragmatics
eScholarship (California Digital Library) · 18.06.2025
DOI: 10.48448/zh0n-cg32 ↗Kurz gefasst
Fachartikel in der Zeitschrift eScholarship (California Digital Library), erschienen am 18.06.2025. Verfasst von Cognitive Science Society 2025 und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Pragmatic atypicality is widely considered to be a central characteristic of autism. This is often explained as a consequence of Theory of Mind deficits. However, this account is flawed and biased. In this paper, we revisit the Double Empathy Problem and provide an experience-first approach to autistic pragmatics. We start with proposing a mechanistic explanation of a link between experiential differences and intentionality understanding in linguistic contexts using the Interpretive Sensory Access theory. Then, we explain how theories of common ground in communication involve factors beyond intention recognition and even beyond cooperation, highlighting how the egocentric nature of communication is relevant to one’s attention and experiences. Taken together, we put forward an experience-based approach to understand autistic pragmatic atypicalities. This view is compatible with many other non-linguistic characteristics well-documented in autism, and prioritizes the experience of autistic people, instead of framing it as a communication disorder with a “mind-reading failure”.
Schlagwörter
Zitieren
APA
2025, C. S. S., Luo, D., & Xin, Y. (2025). An Experience-First Approach to Autistic Pragmatics. eScholarship (California Digital Library). https://doi.org/10.48448/zh0n-cg32
Vancouver
2025 CSS, Luo D, Xin Y. An Experience-First Approach to Autistic Pragmatics. eScholarship (California Digital Library). 2025. doi:10.48448/zh0n-cg32
BibTeX
@article{2025,
author = {2025, Cognitive Science Society and Luo, Dezhi and Xin, Yage},
title = {An Experience-First Approach to Autistic Pragmatics},
journal = {eScholarship (California Digital Library)},
year = {2025},
doi = {10.48448/zh0n-cg32}
}
EUVIMED